Home › Kanser sa Bato › Florida
Pag-aaral pangklinika para sa Kanser sa Bato sa Florida
13 pag-aaral para sa Kanser sa Bato ang naghahanap ng mga kalahok sa mga site sa Florida.
Mga Lungsod sa Florida
Opisyal na teksto ng pag-aaral (English)
A Phase 1 Study of AB521 Monotherapy and Combination Therapies in Renal Cell Carcinoma and Other Solid Tumors
- Research Site, Miami
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 13, 2026 · NCT05536141Open-Label Phase 1/2 Study of NEO-811 in Subjects With Locally Advanced or Metastatic Non-Resectable Clear Cell Renal Cell Carcinoma
- NEO-811 Florida Site, Miami
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT07300241Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma
- Research Site, Jacksonville
- Research Site, Miami
- Research Site, Orlando
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 2, 2026 · NCT07011719Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
- Mayo Clinic Jacksonville, Jacksonville
- Moffitt Cancer Center, Tampa
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 26, 2026 · NCT04981119Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
- Sylvester Comprehensive Cancer Center - University of Miami Health System, Miami
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 15, 2026 · NCT06239194KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors
- AdventHealth Celebration, Celebration
- Mayo Clinic Comprehensive Cancer Center, Jacksonville
- Florida Cancer Specialists, Sarasota
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 14, 2026 · NCT06026410Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
- Mayo Clinic Pharmacy, Jacksonville
- Orlando Health Cancer Institute, Lake Mary
- Orlando Health Ambulatory Care Center, Orlando
- at 2 pa
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 8, 2026 · NCT07227415Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma
- Xencor Investigative Site, Jacksonville
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 3, 2026 · NCT05433142Integrated Cancer Repository for Cancer Research
- Florida Hospital Memorial Medical Center, Daytona Beach
- Florida Hospital DeLand, DeLand
- Florida Hospital FISH, Orange City
- at 2 pa
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 19 hanggang 110 · Lahat ng kasarian · Na-update Hun 29, 2026 · NCT02012699A Study of VET3-TGI in Patients With Solid Tumors
- University of Miami, Miami
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Abr 7, 2026 · NCT06444815SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Jacksonville
- Massive Bio SYNERGY-AI site, Miami
- Massive Bio SYNERGY-AI site, Tampa
Nagre-recruitObservasyonal na pag-aaral
Lahat ng edad · Lahat ng kasarian · Na-update Okt 28, 2025 · NCT03452774A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression
- Mayo Clinic, Jacksonville
- Moffitt Cancer Center, Tampa
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 9, 2025 · NCT06682793Cryaoablation Assisted Partial Nephrectomy a Non Ischemic Approach
- Urological Research Network, Miami Lakes
Nagre-recruit
Edad 55 hanggang 65 · Lahat ng kasarian · Na-update Ene 26, 2023 · NCT05218811Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.